Component information
No US or EU label exists for this exact combination, so information is shown for each component.
Use: Acute mild to moderate pain (adults) renalcarematters.com, reviewed
Kidney dosing: Dexketoprofen (single-agent)Show full dosing details
- CrCl ≥60 mL/min
- CrCl ≥90: 25 mg every 8 hours, maximum 75 mg/day, shortest course. CrCl 60–89: start at 50 mg/day total (SmPC). Injection: 50 mg every 8 to 12 hours, maximum 150 mg/day, no more than 2 days; CrCl 60–89: 50 mg/day total (injection SmPC).
- CrCl 30–59 mL/min
- Contraindicated: moderate to severe kidney dysfunction (CrCl ≤59 mL/min) (oral and injection SmPCs).
- CrCl 15–29 mL/min
- Contraindicated: moderate to severe kidney dysfunction (CrCl ≤59 mL/min) (oral and injection SmPCs).
- CrCl <15 mL/min (not on dialysis)
- Contraindicated: moderate to severe kidney dysfunction (CrCl ≤59 mL/min) (oral and injection SmPCs).
- Hemodialysis (intermittent)
- Contraindicated (CrCl ≤59; SmPC).
- Peritoneal dialysis
- Contraindicated (CrCl ≤59; SmPC). NSAIDs also hasten loss of residual kidney function.
- CRRT
- Contraindicated (CrCl ≤59; SmPC); NSAIDs worsen acute kidney injury.
- Dialyzable? Not stated (99% protein-bound).
- Monitoring Kidney function, potassium and fluid status, especially with diuretics, ACE inhibitors, ARBs or volume depletion; keep the patient hydrated. Gastrointestinal bleeding. Shortest course (SmPC 4.4).
From the Dexketoprofen monograph (renalcarematters.com, reviewed).
Use: Tramadol hydrochloride tablets are indicated in adults for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. US FDA label
Kidney dosing: Tramadol (single-agent)Show full dosing details
- CrCl ≥60 mL/min
- IR: 50 to 100 mg every 4 to 6 hours as needed after titration, maximum 400 mg/day; over 75 years, maximum 300 mg/day (label). ER: usual dosing, maximum 300 mg/day (label).
- CrCl 30–59 mL/min
- IR: no adjustment at CrCl ≥30 (label). ER: no consistent change in tramadol exposure at CrCl 30–80; M1 exposure 20–40% higher (label). Use with caution.
- CrCl 15–29 mL/min
- IR: increase the dosing interval to every 12 hours, maximum 200 mg/day (label: CrCl <30). ER: do not use (label).
- CrCl <15 mL/min (not on dialysis)
- IR: increase the dosing interval to every 12 hours, maximum 200 mg/day (label: CrCl <30). ER: do not use (label).
- Hemodialysis (intermittent)
- IR: dose as for CrCl <30 (every 12 hours, maximum 200 mg/day); give the regular dose on dialysis days, since less than 7% is removed in a 4-hour dialysis (label). ER: do not use.
- Peritoneal dialysis
- IR: not studied in peritoneal dialysis. Clinical extrapolation: dose as for CrCl <30 (every 12 hours, maximum 200 mg/day). ER: do not use.
- CRRT
- No data in the IR or ER labels. IR: specialist input (the CrCl <30 schedule is a reasonable starting point but is not studied in CRRT). ER: do not use.
- Dialyzable? No: less than 7% removed in a 4-hour dialysis (label).
- Monitoring Respiratory depression, sedation, seizures, serotonin syndrome, hypoglycemia, hyponatremia; opioid boxed warnings.
From the Tramadol monograph (renalcarematters.com, reviewed).
Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney dosing for each component (single-agent) is shown under Component information.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Film-coated tablet: 75 mg/25 mg
Registered products in the Philippines
1 product registered with the Food and Drug Administration (FDA) Philippines list Dexketoprofen + Tramadol as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
SkudexaTramadol (as hydrochloride) + Dexketoprofen (as trometamol) | 75 mg/ 25 mg Film-Coated TabletAlveolar push through blisters [Alu/Alu, PVC/PE/PVDC/Alu and PVC/PVDC/Alu] x 10's and 2's (Box of 20's and 2's). | Rx | Menarini Von Heyden GmbHGermany | Importer: A. Menarini Philippines, Inc. | DR-XY46409 | Jul 31, 2028 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .